personalized medicine
Metastatic Tumor Subtypes Found With Expression Profiling
Researchers unearthed four metastatic tumor molecular subtypes based on gene expression profiles in patient-derived xenograft and human tumor samples.
Guardant Health, Royal Marsden Partner on Prospective Liquid Biopsy Trial in Early Colorectal Cancer
The study is evaluating the Guardant Reveal assay to guide chemotherapy treatment decisions following surgery for stage II to III colorectal cancer.
Personalis to Lay off up to 30 Percent of Workforce
The company estimated that the reduction will save it approximately $17 million in operating costs for the remainder of this year.
Estonian Team Building Personalized Medicine Center of Excellence With €30M in National, EU Funding
Premium
Among many objectives, the project will perform whole-genome sequencing of 10,000 individuals to build out its reference genome set.
Caris Life Sciences Taps Juniper Biologics to Market Sequencing Tests in Southeast Asia
The move will make Caris' comprehensive cancer sequencing services available to physicians and patients in the region.
Dec 22, 2022
Dec 16, 2022
Nov 7, 2022
Oct 24, 2022
Sep 7, 2022